Lisa Iacono
About Lisa Iacono
Lisa Iacono is the Director of Global Regulatory Strategy for Oncology at Bristol-Myers Squibb, with over 15 years of experience in regulatory affairs within the pharmaceutical industry.
Title and Current Position
Lisa Iacono is the Director of Global Regulatory Strategy in the Oncology division at Bristol-Myers Squibb. She is responsible for leading regulatory strategies for the company's oncology products in global markets.
Work Experience at Bristol-Myers Squibb
Lisa Iacono has held multiple roles at Bristol-Myers Squibb including Principal Documentation Lead (2017-2018), Regulatory Documentation Lead (2014-2017), Associate Director (2010-2014), and Senior Research Investigator (2004-2010). Her diverse roles within the company underscore her extensive experience in both regulatory and research aspects of the pharmaceutical industry.
Previous Positions
Before rejoining Bristol-Myers Squibb, Lisa Iacono worked as a Postdoctoral Fellow at St. Jude Children's Research Hospital from 2001 to 2004. She also had a brief stint as a Howard Hughes Fellow at the Cancer Institute of New Jersey in 2000.
Educational Background
Lisa Iacono earned her Doctor of Pharmacy degree from Rutgers University, where she studied from 1995 to 2001. Her formal education laid a strong foundation for her subsequent career in regulatory affairs and pharmaceutical research.
Expertise in Oncology Regulatory Strategy
With over 15 years of experience in regulatory affairs within the pharmaceutical industry, Lisa Iacono specializes in oncology regulatory strategy. She focuses on global markets and has played a key role in the regulatory approval process for multiple oncology drugs. Her expertise includes documentation and regulatory submissions, making her a valuable asset to Bristol-Myers Squibb's oncology division.